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ApoptosisZapotin, a tetramethoxyﬂavone, is a natural compound with a wide spectrum of activities in neoplastic cells.
Protein kinase C epsilon (PKCε) has been shown to be oncogenic, with the ability to increase cell migration,
invasion and survival of tumor cells. Here we report that zapotin inhibits cell proliferation. In wild-type HeLa
cells with basal endogenous expression of PKCε, the IC50 was found to be 17.9±1.6 μM. In HeLa cells overex-
pressing doxycycline-inducible constitutively active PKCε (HeLaPKCεA/E), the IC50 was 7.6±1.3 μM, suggest-
ing that PKCε enhances the anti-proliferative effect of zapotin. Moreover, we found that zapotin selectively
activated PKCε in comparison with other PKC family members, but attenuated doxycycline-induced PKCε ex-
pression. As a result of zapotin treatment for 6, 12 and 24 h, the doxycycline-induced levels of the two differ-
ently phosphorylated PKCε forms (87 kDa and 95 kDa) were decreased. Migration assays revealed that
increasing concentrations of zapotin (from 3.5 to 15 μM) decreased migration of HeLaPKCεA/E cells. Further-
more, zapotin signiﬁcantly increased the fraction of apoptotic cells in doxycycline-induced (HeLaPKCεA/E)
cells after 24 h and decreased the levels of Bcl-2, c-Jun, c-Fos. This was accompanied by a degradation of
PARP-1. In summary, activation of PKCε and down-modulation of the induced PKCε level by zapotin were as-
sociated with decreased migration and increased apoptosis. These observations are consistent with the pre-
viously reported chemopreventive and chemotherapeutic action of zapotin.
© 2012 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Flavonoids belong to the family of polyphenolic compounds that are
common components of human diet. Epidemiological studies have
shown that consumption of ﬂavonoids is associated with a low risk of
cardiovascular diseases and cancer. Flavones, a group of ﬂavonoids,
are neuroprotective, cardioprotective and chemopreventive agents
acting as antioxidants and modulators of protein kinases and lipid-
dependent signaling pathways (Duraj et al., 2005). The ﬂavone zapotin
(5,6,2′,6′-tetramethoxyﬂavone) was ﬁrst identiﬁed in the tropical fruit
zapote blanco (Casimiroa edulis) (Murillo et al., 2007), later isolated
from Sargentia gregii (Meyer et al., 1985) and extracted from the leaves
of Primula veris (Budzianowski et al., 2005). In a previous study it was
demonstrated that zapotin prevented colon carcinogenesis (Murillo et
al., 2007). In human promyelocytic HL-60 leukemia cells, zapotin
induced both, cell differentiation and apoptosis (Mata-Greenwood etfax: +43 512 9003 73130.
mann).
-NC-ND license.al., 2001). Moreover, zapotin inhibited 12-O-tetradecanoylphorbol-13-
acetate (TPA)-induced ornithine decarboxylase activity in human T24
bladder carcinoma cells and TPA-induced nuclear factor kappa B
(NF-κB) activity in human HepG2 hepatocellular carcinoma cells
(Maiti et al., 2007). However, any inﬂuence of zapotin on protein ki-
nase pathways has not been reported so far. In our work, we focused
on the effects of zapotin on protein kinase C (PKC) which is a family
of ten isozymes comprising (i) the conventional PKCs α, βΙ, βΙΙ, γ,
(ii), the novel δ, ε, θ, η, and (iii) the atypical λ/ι (mouse/human)
and ζ. PKC isozymes play important roles in the activation of signal
transduction pathways leading to synaptic transmissions, the activa-
tion of ion ﬂuxes, secretion, proliferation, cell cycle control, ischemic
preconditioning, differentiation and tumorigenesis. PKC has become
of major interest as a target for therapeutic intervention in a range of
different diseases such as allergy, asthma, rheumatoid arthritis,
transplantation, AIDS, Alzheimer's disease, multiple sclerosis, hyper-
tension, cardiac hypertrophy, ischemic insult, atherosclerosis, diabe-
tes and cancer (Goekjian and Jirousek, 1999). The exact functions of
the different PKC isozymes are not known at present. Here we inves-
tigated the inﬂuence of zapotin on the ten PKC isoenzymes and found
that it selectively activates PKCε.
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2.1. Isolation of zapotin
The leaves of Primula veris L. (cowslip) were collected from the
ﬁeld (A) andmaintained by Dr. Maria Morozowska at the Department
of Botany, Poznań University of Life Sciences, Poznań, Poland; in
vitro cultures (B) were obtained by Dr. Maria Wesołowska at the
Department of Pharmaceutical Botany and Plant Biotechnology, as
described by Budzianowski et al. (2005). The dried leaves of each
collection (A and B, each 80.0 g) were separately extracted with
chloroform under reﬂux (7× 600 ml/h). The concentrated extracts
(A: 8.0 g, B: 6.3 g) were separately chromatographed over cellulose
CF-11 columns (Whatman, Maidstone, UK), eluted with a methanol–
water mixture (ratio 7:3, v/v), and subsequently eluted from polyam-
ide columns (Roth, Karlsruhe, Germany) with methanol to yield
crude lipophilic ﬂavone fractions (A: 3.4 g, B: 2.3 g). Portions of each
of those fractions (A: 1.5 g, B: 1.8 g) were combined and separated on
a silica gel column (Merck, Darmstadt, Germany) eluted with hexane,
hexane–ethyl acetate mixtures (ratio 9:1, 8:2, 7:3, 6:4, v/v) and ethyl
acetate to give fractions containing various mixtures of lipophilic ﬂa-
vones. The fractions containing zapotin were separated by preparative
thin-layer chromatography on polyamide 6 (Macherey-Nagel, Düren,
Germany) using acetic acid–water mixture (ratio 3:7, v/v) and on silica
gel using hexane–ethyl acetate mixture (ratio 7:3, v/v) to give crude
zapotin. This was puriﬁed by two-step column chromatography on
Sephadex LH20 (Amersham-Pharmacia, Dübendorf, Switzerland)
using methanol of HPLC grade and a mixture of redistilled ethanol
and double distilled water (ratio 4:1, v/v) to yield a pure compound
as white crystals from methanol (97 mg). For the experiments, a
40 mM stock solution in DMSO was used.
2.2. NMR identiﬁcation of zapotin
The identity of the isolated zapotin sample was determined by 1H
(400 MHz) and 13C (100 MHz) NMR spectra recorded for the solution
in deuterated chloroform (CDCl3) and compared to the spectral data
previously published (Budzianowski et al., 2005). The purity of zapotin
was determined to be 95% from the integrals observed in the 1H NMR
spectrum. Those integrals indicated 18 protons for zapotin and 2 pro-
tons for an impurity, which was visible as a broad singlet at 1.78 ppm
and hence considered to correspond to water crystallization.
2.3. Cell culture
The HeLaPKCεA/E subline was derived from parental HeLa wild-
type cells (HeLaWT; human epitheloid cervix carcinoma cells; ATCC
No. CCL-2) by transfection with a pUHD 172-1-neo vector carrying a
tetracycline/doxycycline-inducible Tet-on vector (Clontech, Palo
Alto, CA) containing a constitutively active rat PKCε (PKCεA/E,
Ala159 is replaced by Glu) (Garczarczyk et al., 2009). In this cell line
the expression of PKCεA/E can be induced with 2 μg/ml doxycyline.
This mutated form of PKCε is constitutively active without activators
such as TPA. Cells were cultured in RPMI 1640 medium supplemented
with 2 mM glutamine (Sigma Chemicals, Munich, Germany), 10%
Tet-approved fetal bovine serum (Clontech, Mountain View, USA),
100 μg/ml geneticin and 100 μg/ml hygromycin (both from Roche
Diagnostics, Mannheim, Germany). HeLaWT cells were cultured in
RPMI 1640mediumwith 10% fetal bovine serumand 50 μg/ml gentami-
cin (Sigma Chemicals, Munich, Germany).
2.4. Cell proliferation assay
Zapotin cytotoxicity was assessed as previously described (Rubis
et al., 2008) using the MTT Proliferation Assay (Cell Proliferation Kit,
Roche Diagnostics, Mannheim, Germany). Brieﬂy, ~3000 HeLaWT orHeLaPKCεA/E cells/well were seeded in 96-well microplates and ex-
posed to 1–25 μM of zapotin for 72 h. Cell viability was quantiﬁed
using a Labsystems Multiscan RC spectrophotometer. IC50 values
were calculated with CalcuSyn (Biosoft, Cambridge, UK) and standard
deviation with Excel software. The ﬁnal concentration of DMSO in the
medium of controls and zapotin-treated cells was 0.1% and this did
not show any effect on cell proliferation. The mean of 3 experiments,
each in duplicate (+/−S.D.), is indicated in Fig. 2.
2.5. Western blot analysis
HeLaPKCεA/E cells were treated with 7.5, 15, 30 μM zapotin or
2 μg/ml doxycycline, or a combination of both compounds. Whole
cell extracts were prepared using lysis buffer (50 mM Tris–HCl, pH
7.5, 150 mM NaCl, 2 mM EDTA, 1 mM EGTA, 1% Triton X-100,
100 mM PMSF, 25 μg/ml Na3VO4, 25 μg/ml NaF, 25 μg/ml leupeptin
and 25 μg/ml aprotinin) as previously described (Garczarczyk et al.,
2009). Protein concentration was measured with the Bradford assay
(Sigma, Munich, Germany) and 30 μg (or 60 μg for phospho PKCε
detection) of each extract was loaded onto SDS-PAGE ready gels
(BioRad, Hercules, CA). Western blotting was performed by a
standard procedure using PVDF membrane (Pierce Biotechnology,
Rockford, USA). The following antibodies were used for detection:
anti-PKCε, anti-pPKCε(Ser729), anti-PKCδ, anti-Bcl-2, anti-c-Jun,
anti-c-Fos, anti-PARP-1, anti-NF-κB, anti-pNF-κB(Ser536), anti-actin,
anti-GAPDH, anti-tubulin (all from Santa Cruz Biotechnology);
1 μg/ml of each primary antibody was used in the blotting solution.
The proteins were visualized using SuperSignal® West Pico
Chemiluminescent Substrate and a CL-X Posure™ ﬁlm (Pierce
Biotechnology, Rockford, USA). The optical density (Arbitrary Units)
of the bands was measured using LabWorks software (UVP, Upland,
CA). In Figs. 4 and 5, representatives of two experiments are shown.
To prepare the nuclear and cytosolic fractions, cells were homog-
enized in ice-cold lysis buffer (10 mM Hepes (pH 7.4), 1.5 mM
MgCl2, 10 mM KCl and 5 mg/ml aprotinin and 5 mg/ml leupeptin)
for 5 min as described by Brodsky et al. (2010). The extract was cen-
trifuged at 2400 g for 15 min, and the supernatants were centrifuged
for 45 min at 14,000 g. The cytosolic extract was stored at 4 °C. The
nuclear pellet was resuspended and incubation for 45 min in lysis
buffer containing 20 mM Hepes (pH 7,4) 0.42 M NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA and 5 mg/ml aprotinin, and 5 mg/ml leupeptin.
The nuclear lysates were centrifuged for 45 min at 14,000 g and the
supernatant containing the soluble nuclear proteins was taken for
further experiments. Protein concentrations were measured with
the Bradford assay, and 40 μg protein from each extract was loaded
onto 7–12% SDS-PAGE gels (BioRad, Hercules, CA). In Fig. 8, the
scans of one representative experiment (out of three) are shown.
2.6. PKC activity
PKC assays were performed with 150 ng of each recombinant
PKC isozyme (Proqinase, Freiburg, Germany) in 100 μl of 20 mM
Tris–HCl pH 7.5, 20 mMMgCl2, 1 mM CaCl2, 50 μM substrate peptide
(PKCα-19–31, RFARKGSLRQKNV; NeoMPS, Strasbourg, France), 10 μM
phosphatidylserine, 1 μM TPA (Sigma, Munich, Germany), 40 μM ATP
and 1 μCi γ-33P-ATP (NEG602H, PerkinElmer, Waltham, MA). Zapotin
was dissolved in DMSO. In untreated controls (set as 100%), the same
volume of DMSO was added as in the zapotin-treated samples. After
10 min incubation at 30 °C, 50 μl of the reaction mix was transferred
to a phosphocellulose disk (Whatman, Dassel, Germany), washed
three times with 1.5% phosphoric acid and twice with distilled water.
Subsequently, the disks were transferred into scintillation vials, and
3 ml of Ultima Gold (PerkinElmer, Waltham, MA) was added for
determining the 33P incorporation in a liquid scintillation counter.
The data shown represents means of at least three independent
experiments, each in triplicates (+/−S.D.).
Fig. 2. Inﬂuence of zapotin on cell viability. Cell proliferation was measured with theMTT
assay. HeLaWT and HeLaPKCεA/E cells were seeded at a density of ~3000 cells/well in a
96-well microplate and exposed for 72 h to 1, 2.5, 5, 10, 15 and 25 μM zapotin. Cell
proliferation was quantiﬁed spectrophotometrically. The ﬁnal concentration of DMSO in
the medium of controls and zapotin-treated cells was 0.1%.
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For cell migration and motility, a scratch migration assay de-
scribed by Cha et al. (1996) was employed. In a 60 mm tissue culture
dish with logarithmically growing HeLaPKCεA/E cells, a migration gap
of approximately 1 mm was created by introducing a ‘scratch’ to the
adherent layer of cultured cells using a sterile Gilson 200 μl pipette
tip. The scratch was administered by hand with sufﬁcient pressure
to remove adherent cells from the polystyrene substrate, but without
causing a physical damage to the polystyrene surface. The dish was
washed with PBS to remove the detached cells and further incubated
for 12 h. This was followed by a wash with phosphate buffered saline.
Cells were then treated with zapotin (3.75–15 μM) and/or doxycy-
cline (2 μg/ml) or calphostin C (500 nM) for the indicated times.
After microscopic observation, photographs were taken (Axiovert 40
CFL, Zeiss, Göttingen, Germany). A representative of three experi-
ments is shown.
2.8. Cell cycle analysis
After culturing for 16 h, cells were treated with zapotin (15 μM)
and/or doxycycline (2 μg/ml), and after a further incubation for
24 h, cell cycle analysis was performed. Cells were collected using
0.25% trypsin (Sigma, Munich, Germany) and cell pellets were resus-
pended in 100 μl of phosphate buffered saline containing 250 μg/ml
propidium iodide and 25 μl ribonuclease A (10 mg/ml; Sigma, Munich,
Germany). After incubation in the dark at room temperature for 1 h,
ﬂow cytometry analysis was performed (FacSCAN, Becton-Dickinson,
Franklin Lakes, NJ). The mean of three experiments in duplicate
+/−S.D. is shown.
2.9. Statistical analysis
The data shown are means from at least three separate experi-
ments unless speciﬁed otherwise. Statistical analysis was performed
by one-way ANOVA (GraphPad Prism, San Diego, CA). Pb0.05 was
considered as signiﬁcant difference.
3. Results
HeLaWT cells were treated with zapotin (Fig. 1) for 72 h and the
IC50 value was found to be 17.9±1.6 μM. In HeLaPKCεA/E cells over-
expressing PKCεA/E following induction with doxycycline, the IC50
was 7.6±1.3 μM (Fig. 2). Thus, zapotin exhibited a signiﬁcantly
(Pb0.05) higher cytotoxic effect in cells expressing PKCεA/E. The
difference between the IC50 values in HeLaWT and doxycycline-
induced HeLaPKCεA/E cells indicated that PKCε signaling is involved
in zapotin-induced cytotoxicity.O
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Fig. 1. Chemical structure of zapotin (5,6,2′,6′-tetramethoxyﬂavone).In order to determine whether zapotin exhibits any inﬂuence on
PKC family members, an in vitro assay with all the ten recombinant
PKC isozymes was performed. As shown in Fig. 3A, zapotin was a se-
lective activator of PKCε. The activation of recombinant PKCε was
dose-dependent and signiﬁcant as calculated by the Student's t-test
(15 μM zapotin/control P=0.0001, 30 μM zapotin vs control
P=0.0009). Other PKC isozymes were not affected signiﬁcantly by
zapotin (Fig. 3A). Even if the PKC activators phosphatidylserine and
diacylglycerol were omitted, or the PKC inhibitor bisindolylmalei-
mide I (BIM) was added, also a trend to activate PKCε was observed
(Fig. 3B).
Usually, PKC family members are down-modulated after activa-
tion. Therefore, we investigated the inﬂuence of zapotin on PKCε
expression in HeLaPKCεA/E cells. As shown in Fig. 4, doxycycline-%
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Fig. 3. Effect of zapotin on PKC isozymes in vitro. A) 150 ng of the different recombi-
nant PKC isozymes were incubated in presence of calcium, TPA and phosphatidylserine
with a substrate peptide as described in Materials and methods. Controls without
zapotin were set as 100% for each PKC isozyme. **15 μM zapotin/control P=0.0001
and 30 μM zapotin/control P=0.0009. B) Effect of zapotin on PKCε. Activators were
phosphatidylserine and diacylglycerol as indicated in Materials and methods. BIM,
bisindolylmaleimide. **, P=0.003.
10‘ 2h 6h  12h 24h
Control Zapotin Zapotin Zapotin Zapotin Zapotin
PKCε
PKCδ
Tubulin
0
50
100
%
 o
f c
on
tro
l 
0
50
100
%
 o
f c
on
tro
l
PKCε
PKCδ
Fig. 4. Inﬂuence of zapotin on the expression of doxycycline-induced PKCε. The nearest
homologue of PKCε, PKCδ was employed as control. The expression of PKCε was in-
duced with doxycycline for 24 h. Zapotin was added together with doxycycline at the
start of the 24 h-treatment, and 12 h, 6 h, 2 h and 10 min before the end of the exper-
iment. PKCδ was detected under the same conditions. Western blot analysis was per-
formed as described in Materials and methods. The results are shown as relative to
loading control, tubulin.
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Fig. 5. Inﬂuence of zapotin on PKCε expression in HeLaPKCεA/E cells. Western blot
analysis was performed with 30 μg of protein extract separated in SDS-PAGE and
detected with anti-PKCε antibody and with a PKCε phospho-Ser729 antibody. For den-
sitometric analysis of the two PKC isoforms, GAPDH was employed as internal stan-
dard. Dox 24 h, 2 μg/ml doxycycline; Zap 24 h, 15 or 30 μM zapotin; (Dox+Zap)
24 h, concomitant treatment with 2 μg/ml doxycycline and 15 or 30 μM zapotin for
24 h; Dox 24 h+Zap 24 h, doxycycline 2 μg/ml for 24 h followed by a wash and subse-
quent treatment with 15 or 30 μM zapotin for another 24 h. BIM, bisindolylmaleimide.
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order to determine whether the down-modulation by zapotin is spe-
ciﬁc for PKCε, its closest homologue, PKCδwas investigated. As shown
in Fig. 4, PKCδ was down-modulated to a lesser extent by zapotin,
illustrating a preference of this compound for PKCε. The most pro-
nounced down-modulation of PKCεA/E was observed after 24 h.
Therefore, for the following experiments this period of time was
employed. PKCεwith the molecular mass of 87 kDa is phosphorylated
at Thr566 and Ser703, and PKCε with the molecular mass of 95 kDa is
additionally phosphorylated at Ser729 (England et al., 2001;
Garczarczyk et al., 2009). Immunodetection in a gel which allows sep-
aration of both forms revealed that in HeLaPKCεA/E cells doxycycline
signiﬁcantly induced both PKCε isoforms by over 2-fold after 24 h
treatment (Fig. 5). Simultaneous treatment with doxycycline and
zapotin reduced the doxycycline-inducing effect of both differently
phosphorylated forms (Fig. 5, (Dox+Zap 24 h), ~30%, Pb0.05).
It has been shown previously that PKCε is involved in cell migration
and invasion (England et al., 2001; Garczarczyk et al., 2009). Therefore,
the inﬂuence of zapotin on cell migration of PKCεA/E cells was investi-
gated. After a scratch made in a monolayer (Fig. 6A), doxycycline-
induced PKCεA/E overexpression led to increased migration (Fig. 6C)
compared to untreated control cells (Fig. 6B). Increasing doses of
zapotin (3.75, 7.5 and 15 μM) attenuated the enhanced migration of
doxycycline-induced cells overexpressing PKCεA/E (Fig. 6D, E and F,
respectively). The general PKC inhibitor calphostin C was used as a con-
trol (Fig. 6G).
Next we tested the effects of zapotin on the cell cycle and on apo-
ptosis. HeLaPKCεE/A cells with and without doxycycline-inducedPKCεA/E expression showed very similar cell cycle proﬁles with ap-
proximately 5% apoptotic cells (Fig. 7). HeLaPKCεE/A cells treated
only with zapotin (15 μM) for 24 h revealed a signiﬁcant decrease
(Pb0.05) in the number of G0/G1 cells (>25% decrease compared
to controls) and a signiﬁcant increase (Pb0.05) in apoptotic cells
(up to 30%). This effect was very similar to that observed in the anal-
ysis of cells treated simultaneously with doxycycline and zapotin
(Dox+Zap 24 h). When cells were treated with doxycycline for
24 h followed by treatment with zapotin for another 24 h, no signiﬁ-
cant alteration in the cell cycle proﬁle was observed compared to
untreated controls or cells with doxycycline-induced PKCεA/E ex-
pression. These results were conﬁrmed by the assessment of PCNA
accumulation. This S-phase-speciﬁc marker was not altered in any
of the investigated samples (data not shown). However, a signiﬁcant
increase (Pb0.05) of apoptotic cells up to over 11% was observed after
concomitant treatment with doxycycline and zapotin (Fig. 7).
As zapotin increased the percentage of apoptotic cells (Fig. 7), pro-
teins involved in apoptosis were investigated. Induction of PKCεA/E
with doxycycline did not signiﬁcantly alter the level of Bcl-2 protein
(Fig. 8A). Zapotin alone (Zap 24 h, 15 μM) caused a signiﬁcant
(Pb0.05) decrease in the level of Bcl-2 by almost 40% compared to
control cells. This effect was weaker but still signiﬁcant in cells incu-
bated simultaneously with doxycycline and zapotin (Dox+Zap;
24 h) (approximately 20%) (Pb0.05). An intermediate effect was ob-
served when cells were treated with zapotin and doxycycline for 24 h
(30% decrease compared to control cells) (Fig. 8A). Poly [ADP-ribose]
polymerase 1 also known as NAD+ ADP-ribosyltransferase 1 (PARP-1),
is a substrate of caspase 3 (Chow et al., 2008). The proteolytic degrada-
tion of PARP-1 by caspase 3 is a hallmark of apoptosis. The analysis of
PARP-1 (Fig. 8B) revealed no change after doxycycline treatment. How-
ever, all treatment protocols with zapotin (zapotin alone, doxycycline
and zapotin for 24 h, doxycycline 24 h and subsequently zapotin for
24 h) led to PARP-1 degradation. Doxycycline+calphostin C were
employed as a control (Fig. 8B).
The analysis of c-Jun showed that treatment of PKCεA/E cells with
zapotin led to a signiﬁcant decrease (over 90% decrease relative to
control, Pb0.05) (Fig. 8A). A similar effect was observed after treat-
ment with a combination of the two compounds ((Dox+Zap)
24 h). However, when cells were successively incubated with the
two compounds (Dox 24 h+Zap 24 h), no change in c-Jun was
found. A similar proﬁle was observed with c-Fos. A downregulation
of protein expression by over 50% in cells treated with zapotin alone
or with jointly both compounds (Dox+Zap; 24 h) was found. When
cells were treated ﬁrst with doxycycline for 24 h and thereafter
with zapotin for another 24 h (Dox 24 h+Zap 24 h), a signiﬁcant
(Pb0.05) increase (almost 80% compared to control) of c-Fos protein
expression was demonstrated (Fig. 8A).
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Fig. 6. Inﬂuence of zapotin on cell migration. HeLaPKCεA/E cells were incubated with doxycycline, zapotin or calphostin C on 60-mm dishes for 24 h. Migration of HeLaPKCεA/E cells
into a scratch of logarithmic growing cells made with a pipette tip was assessed microscopically.
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Fig. 8. Effect of zapotin on expression levels of proteins involved in apoptosis. A) HeLaPKCεA/E cells were grown in the presence of 2 μg/ml doxycycline, 7.5 or 15 μM zapotin, or a
combination of both for 24 h; 30 μg of cell lysate was loaded onto the gels. (Dox+Zap) 24 h, concomitantly 2 μg/ml doxycycline and 15 μM zapotin for 24 h; Dox 24 h+Zap 24 h,
doxycycline 2 μg/ml for 24 h followed by a wash and subsequent treatment with 15 μM zapotin for another 24 h. B) PARP-1, NFκB and NFκB-phospho-Ser536 were detected. Legend
is as described in A.
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sis. Upon activation, an IκB kinase/NF-κB complex is split and NFκB is
translocated to the nucleus to activate a series of genes. In an alterna-
tive pathway it is activated by phosphorylation. As shown in Fig. 8B,
NF-κB levels were not altered or translocated to the nucleus signiﬁ-
cantly under zapotin treatment. However, the phosphorylated form
of NF-κB was reduced after each of the zapotin treatments, indicating
less inhibition of apoptosis.
4. Discussion
Plants represent a rich source of pharmacologically active com-
pounds. Flavones, representing the ﬂavonoid family, have potent
anticancer properties. They have also been shown to exert chemopre-
ventive effects (Cuendet et al., 2008; Gupta et al., 2002; Lepley et al.,
2006; Lim et al., 2007; Murakami et al., 2000) by modulating prolifer-
ation and differentiation and inducing apoptosis in colon (Pan et al.,
2002), breast (Ullmannova and Popescu, 2007) and prostate cancer
cells (Gupta et al., 2002; Lepley et al., 2006). An increased number
of methoxyl groups in the basic skeleton of the aglycone of ﬂavones,
especially in the A ring (Fig. 1), results in an increased antiprolifera-
tive activity (Li et al., 2007; Walle, 2007). Moreover, inhibition of pro-
liferation by ﬂavones was observed selectively in cancer cells (Walle,
2007). A high antiproliferative potential of the polymethoxyﬂavones
tangeretin and nobiletin is well documented in various types ofcancers (Li et al., 2007; Morley et al., 2007). Cytotoxic activity of the
tetramethoxyﬂavone zapotin, isolated from Casimiroa edulis was
demonstrated in T24 and HepG2 cells (Maiti et al., 2007). The present
study showed that the IC50 value for inhibition of proliferation was
lower in cells overexpressing constitutively active PKCε than in
HeLaWT cells (7.6 vs. 17.9 μM). PKCε is known to play a crucial role
in neoplastic transformation (Hofmann, 2004; Jobbagy et al., 1999).
Overexpression of PKCε has been observed in cancer of the prostate,
lung, breast, liver and thyroid gland. PKCε has been reported to be as-
sociated with tumor promotion along the Ras/Raf/MAPK phosphory-
lation cascade (Bae et al., 2007; Basu and Sivaprasad, 2007; England
et al., 2001). It was reported that in MCF7 breast cancer cells, overex-
pression of PKCε mediates an antiapoptotic effect partly by prevent-
ing activation and translocation of Bax to the mitochondria (Lu et
al., 2007). PKCε downregulation may thus represent one anticancer
strategy. As shown in Fig. 3, PKCε is activated by zapotin which
leads to a down-modulation of its protein expression (compared to
untreated controls) after 6 h and 12 h (Fig. 4).
PKC is a family of serine/threonine-speciﬁc protein kinases with at
least ten different isozymes. The exact functions of the different PKC
isozymes are not yet clear. Selective activators or inhibitors of these
PKC isozymes could be helpful to elucidate their functions and also
for pharmaceutical purposes. Most inhibitors of kinases interact
with the ATP-binding site that is well conserved among kinase fami-
lies. This poses a serious hurdle for the development of isozyme-
27E. Toton et al. / European Journal of Pharmacology 682 (2012) 21–28selective inhibitors. Several activators such as TPA or bryostatin
nonspeciﬁcally activate a series of PKC isozymes. Ingenol is a PKCε
and δ isozyme-selective activator (Armstrong and Ganote, 1994).
8-[2-(2-pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid (DCP-
LA), a linoleic acid derivative, activates PKCε and to a lesser extent
PKCγ (Kanno et al., 2006). Bisphosphatidic acid was found to be a
strong activator of PKCε, and a weak one of PKCα (Limatola et al.,
1994). Benzyladriamycin-14-valerate was shown to be cardioprotec-
tive through PKCε activation (Hofmann et al., 2007). 12(S)-HETE acti-
vated PKCε, whereas α and θ were not affected. (Mikule et al., 2003).
As our experiments show, zapotin can be used to selectively activate
PKCε (Fig. 3) and down-modulate its protein expression (Figs. 4 and
5). Other activators of PKC, such as TPA or bryostatin, also lead to
down-modulation of PKC isozymes.
Zapotin induced a dose-dependent decrease in migration of
HeLaPKCεA/E cells (Fig. 6). Signiﬁcant inhibition of migration was ob-
served at relatively low concentrations of zapotin (starting with
3.75 μM) that showed only a slight cytotoxic effect (approximately
20% compared to untreated controls, Fig. 2). Furthermore, zapotin sig-
niﬁcantly decreased the percentage of cells in the G1 phase of the cell
cycle and increased the amount of apoptotic cells (up to about 30%).
Elevated expression of PKCεA/E following doxycycline treatment de-
creased the apoptotic effect of zapotin, demonstrating pro-survival
effects of this PKC isozyme (Fig. 7). Previous studies revealed ﬂavones
as inducers of apoptosis with cleavage of PARP-1 (Chen et al., 2004;
Singh et al., 2006). We found that each of the different treatments
with zapotin induced cleavage of PARP-1, illustrating activation of
the pro-apoptotic caspase 3. The degradation of PARP-1 was accom-
panied by increased apoptosis in HeLaPKCεA/E cells (Figs. 7, 8).
Overexpression of Bcl-2 was observed in most of human neoplas-
tic cells and was found in 40–80% cases of breast (Aggarwal et al.,
2007), prostate (McDonnell et al., 1997), lung (Ohmura et al., 2000)
and neuroendocrine tumors (Brambilla et al., 1996). It was suggested
that a ﬂavonoid-mediated effect could contribute to the decrease of
Bcl-2 in neoplastic cells (Shim et al., 2007; Shukla and Gupta, 2004).
The decrease in Bcl-2 following zapotin treatment might contribute
to the pro-apoptotic effect of zapotin in HeLaPKCεA/E cells. Zapotin
was also shown to inhibit TPA-induced ornithine decarboxylase activ-
ity in human bladder carcinoma cells and TPA-induced NF-κB activity
in human hepatocellular carcinoma cells (Maiti et al., 2007). Our
study revealed that zapotin treatment reduced the level of phosphor-
ylated NF-κB slightly (Fig. 8B). Since NF-κB plays an important role as
an apoptosis inhibitor and Bcl-2 inducer (Gupta et al., 2002; Kundu et
al., 2006; Shim et al., 2007; Shishodia and Aggarwal, 2002), the down-
regulation of Bcl-2 in zapotin-treated cells (Fig. 8E) is consistent with
zapotin-mediated apoptosis induction.
In conclusion, our results show that, under zapotin treatment, cell
proliferation in PKCε-overexpressing HeLaPKCεA/E cells was de-
creased to a higher extent than in HeLaWT cells. Zapotin selectively
activated and down-modulated PKCε which seems to be involved in
cancer metastasis. Furthermore, zapotin increased the percentage of
apoptotic cells and decreased cell migration, the percentage of cells
in G1 and the protein levels of Bcl-2, c-Jun, c-Fos and the level of
phosphorylated NFκB. It led to a degradation of PARP-1. These obser-
vations give an indication of the mechanism of the chemopreventive
and chemotherapeutic anticancer activities of zapotin reported
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